Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Greiner

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
Transfusion|February 17, 2025
Increasing use of CAR-T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6-year period: Resource utilization implicationsAswath P Chandrasekar, Margret A DiGuardo, Jeffrey L Winters, et al.
Materials (Basel, Switzerland)|April 30, 2021
Spongostan<sup>™</sup> Leads to Increased Regeneration of a Rat Calvarial Critical Size Defect Compared to NanoBone<sup>®</sup> and ActifuseDirk Wähnert, Julian Koettnitz, Madlen Merten, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patientsF Guadagni, M Roselli, T Amato, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaJ Schlom, D E Milenic, M Roselli, et al.
Cytotherapy|March 19, 2005
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaA B Dietz, D J Padley, G W Butler, et al.
ESMO Open|November 30, 2024
Measuring financial distress in German cancer patients: development and validation of the Financial Distress of Cancer Assessment Tool (FIAT)L Richter, S Pauge, K Mehlis, et al.
Cancer Research|March 1, 1992
CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinomaF Guadagni, M Roselli, T Amato, et al.
Oncotarget|April 1, 2014
The immunocytokine NHS-IL12 as a potential cancer therapeuticJonathan Fallon, Robert Tighe, Giorgio Kradjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigenM Roselli, F Guadagni, O Buonomo, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
Transfusion|February 17, 2025
Increasing use of CAR-T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6-year period: Resource utilization implicationsAswath P Chandrasekar, Margret A DiGuardo, Jeffrey L Winters, et al.
Materials (Basel, Switzerland)|April 30, 2021
Spongostan<sup>™</sup> Leads to Increased Regeneration of a Rat Calvarial Critical Size Defect Compared to NanoBone<sup>®</sup> and ActifuseDirk Wähnert, Julian Koettnitz, Madlen Merten, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patientsF Guadagni, M Roselli, T Amato, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinomaJ Schlom, D E Milenic, M Roselli, et al.
Cytotherapy|March 19, 2005
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaA B Dietz, D J Padley, G W Butler, et al.
ESMO Open|November 30, 2024
Measuring financial distress in German cancer patients: development and validation of the Financial Distress of Cancer Assessment Tool (FIAT)L Richter, S Pauge, K Mehlis, et al.
Cancer Research|March 1, 1992
CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinomaF Guadagni, M Roselli, T Amato, et al.
Oncotarget|April 1, 2014
The immunocytokine NHS-IL12 as a potential cancer therapeuticJonathan Fallon, Robert Tighe, Giorgio Kradjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigenM Roselli, F Guadagni, O Buonomo, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Pageof 21